[HTML][HTML] SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - Plos one, 2023 - journals.plos.org
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

[HTML][HTML] SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - PLOS …, 2023 - ncbi.nlm.nih.gov
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients.

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - 2023 - cabidigitallibrary.org
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - PLoS …, 2023 - ui.adsabs.harvard.edu
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

[PDF][PDF] SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - PLoS ONE, 2023 - scienceopen.com
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - bioRxiv, 2022 - biorxiv.org
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - PloS …, 2023 - pubmed.ncbi.nlm.nih.gov
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - PloS …, 2023 - einstein.elsevierpure.com
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

[HTML][HTML] SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - 2022 - europepmc.org
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients.

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - PLoS …, 2023 - search.ebscohost.com
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …